Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Ricci

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
International Review of Neurobiology|November 10, 2009
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicityFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Neuro-Degenerative Diseases|February 25, 2011
Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin productionNicoletta Croce, Vincenzo Dinallo, Valerio Ricci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 9, 2008
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusersFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Psychopharmacology|December 17, 2010
Chronic ketamine use increases serum levels of brain-derived neurotrophic factorValerio Ricci, Giovanni Martinotti, Francesca Gelfo, et al.
Addiction Biology|November 3, 2011
Enhanced BDNF serum levels in patients with severe pathological gamblingFrancesco Angelucci, Giovanni Martinotti, Francesca Gelfo, et al.
Brain Sciences|January 28, 2026
Structural and Functional Neuroimaging Biomarkers as Predictors of Psychosis Conversion in Ultra-High Risk Individuals: A Systematic ReviewGiovanni Martinotti, Tommaso Piro, Nicola Ciraselli, et al.
Frontiers in Psychiatry|July 17, 2025
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literatureStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Expert Review of Neurotherapeutics|February 27, 2025
Emerging strategies and clinical recommendations for the management of novel depression subtypesStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Journal of Psychopharmacology (Oxford, England)|August 24, 2007
Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factorFrancesco Angelucci, Valerio Ricci, Massimiliano Pomponi, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
International Review of Neurobiology|November 10, 2009
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicityFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Neuro-Degenerative Diseases|February 25, 2011
Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin productionNicoletta Croce, Vincenzo Dinallo, Valerio Ricci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 9, 2008
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusersFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Psychopharmacology|December 17, 2010
Chronic ketamine use increases serum levels of brain-derived neurotrophic factorValerio Ricci, Giovanni Martinotti, Francesca Gelfo, et al.
Addiction Biology|November 3, 2011
Enhanced BDNF serum levels in patients with severe pathological gamblingFrancesco Angelucci, Giovanni Martinotti, Francesca Gelfo, et al.
Brain Sciences|January 28, 2026
Structural and Functional Neuroimaging Biomarkers as Predictors of Psychosis Conversion in Ultra-High Risk Individuals: A Systematic ReviewGiovanni Martinotti, Tommaso Piro, Nicola Ciraselli, et al.
Frontiers in Psychiatry|July 17, 2025
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literatureStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Expert Review of Neurotherapeutics|February 27, 2025
Emerging strategies and clinical recommendations for the management of novel depression subtypesStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Journal of Psychopharmacology (Oxford, England)|August 24, 2007
Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factorFrancesco Angelucci, Valerio Ricci, Massimiliano Pomponi, et al.
Pageof 8